Alternative statutory remedy and unexplained delay barred writ review of customs confiscation adjudication, leaving merits for appellate consideration...
Authorised courier due diligence protects against penalties where declared exports conceal prohibited goods despite proper documentation and customs p...
Customs-controlled container movement now extends to DP World facilities, subject to segregation, inspections, reconciliation, and EXIM cargo priority...
HC determined that a company engaged in manufacturing, incurring expenditure on scientific research and in-house R&D facility approved by the competent authority, is eligible for a 200% deduction under Section 35(2AB)(1). The court rejected the argument of "work-in-progress" as a disqualifying factor, noting the statutory provision only speaks of "expenditure" without distinguishing between completed and ongoing research. The petitioner was entitled to claim benefits for the actual year of expenditure incurrence, particularly given the reliance on prior advisory guidance. The court found in favor of the petitioner, allowing the deduction claim for scientific research expenditure.
HC determined that a company engaged in manufacturing, incurring expenditure on scientific research and in-house R&D facility approved by the competent authority, is eligible for a 200% deduction under Section 35(2AB)(1). The court rejected the argument of "work-in-progress" as a disqualifying factor, noting the statutory provision only speaks of "expenditure" without distinguishing between completed and ongoing research. The petitioner was entitled to claim benefits for the actual year of expenditure incurrence, particularly given the reliance on prior advisory guidance. The court found in favor of the petitioner, allowing the deduction claim for scientific research expenditure.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4828 
Join Channel 
